Physician profile
Horacio J Asbun
NPI 1285638015
$160,853.24
in general payments reported to CMS, 2019-2025
13 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $683 · 2021: $24K · 2022: $4,941 · 2023: $38K · 2024: $50K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,660.00 |
| Travel and Lodging | $37,829.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,980.00 |
| Food and Beverage | $1,932.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $80,495.77 | 2019-2025 | 1788, Spy-Phi System, 1688 |
| Boston Scientific Corporation | $53,026.87 | 2019-2024 | Spyglass Discover, Spyglass |
| Olympus America INC. | $20,107.13 | 2019-2023 | |
| Olympus Corporation | $2,936.19 | 2019 | |
| Ethicon INC. | $2,480.00 | 2021-2022 | |
| Karl Storz Endoscopy-America | $701.29 | 2022 | |
| Intuitive Surgical, INC. | $434.51 | 2019 | |
| Angiodynamics, INC. | $223.95 | 2019 | |
| Ethicon US, LLC | $204.47 | 2020-2025 | Harmonic, Echelon; Endopath |
| Medtronic, INC. | $126.63 | 2024 | Signia |
| W. L. Gore & Associates, INC. | $53.29 | 2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Aimmune Therapeutics, INC. | $34.32 | 2025 | Vowst |
| Daiichi Sankyo INC. | $28.82 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Horacio Asbun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.